Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Gross Margin (2016 - 2026)

OptimizeRx's Gross Margin history spans 13 years, with the latest figure at 74.75% for Q4 2025.

  • On a quarterly basis, Gross Margin rose 661.0% to 74.75% in Q4 2025 year-over-year; TTM through Dec 2025 was 67.25%, a 280.0% increase, with the full-year FY2025 number at 67.25%, up 280.0% from a year prior.
  • Gross Margin hit 74.75% in Q4 2025 for OptimizeRx, up from 67.2% in the prior quarter.
  • Over the last five years, Gross Margin for OPRX hit a ceiling of 74.75% in Q4 2025 and a floor of 54.54% in Q1 2021.
  • Historically, Gross Margin has averaged 61.94% across 5 years, with a median of 62.1% in 2024.
  • Biggest five-year swings in Gross Margin: skyrocketed 863bps in 2021 and later plummeted -768bps in 2023.
  • Tracing OPRX's Gross Margin over 5 years: stood at 61.0% in 2021, then grew by 4bps to 63.37% in 2022, then dropped by -1bps to 62.89% in 2023, then increased by 8bps to 68.15% in 2024, then increased by 10bps to 74.75% in 2025.
  • Business Quant data shows Gross Margin for OPRX at 74.75% in Q4 2025, 67.2% in Q3 2025, and 63.83% in Q2 2025.